Research Interest: Cardiovascular Disease, Electrophysiology, Pacemaker, ICD and CRT Therapy, Metabolic Syndrome, Bidirectional Effect of CVD and CKD

Research Interest: Immunology such as Autoimmune Diabetes (Type 1).

Research Interest: Nutrition, Obesity, Weight, Diet

Research Interest: Integrated Pharmaco-Physiology, Brain-Gut Interactions, Stress-Related Functional Gastrointestinal Diseases, Ingestive Behavior-Associated Gastrointestinal Neuroendocrinology, and Bariatric Surgery

Principal Investigator (PU) – UMR Inserm UMR-S1172

"Alzheimer & Tauopathies" Jean-Pierre Aubert Research Centre, 1 Place de Verdun, Lille, France, didier.vieau@inserm.fr, didier.vieau@univ-lille.fr

Professional experience  

1986-1990: PhD in Endocrinology. Pierre et Marie Curie University of Paris (Paris VI), France. Laboratory of Endocrinology, Cochin Hospital. Thesis supervisor (Pr X. Bertagna). Thesis title: “Proopiomelanocortin and neuroendocrine differentiation markers in human tumoral pathology”

1991-1995: Laboratory of Biochemical Endocrinology (Dr. NG Seidah), Clinical Research Institute of Montreal, Montreal, Canada.

1996-1999: European Institute for Peptide Research (IFRMP 23), Laboratory of Cellular and Molecular Neuroendocrinology (Dr H Vaudry), University of Rouen, 76821 Mont-Saint-Aignan, France.

1999-2002: associate professor in the Laboratory of Endocrinology of Annelids (University of Lille 1, France, Pr M Salzet).

2002-2012: Professor of University (Animal Physiology) and head of the laboratory of maternal perinatal undernutrition (EA4489), University of Lille 1, France.

2012-2016: Dean of the department of Biology of the University Lille 1

September 2016-: Member of UMR Inserm UMR-S1172 "Alzheimer & Tauopathies" (Dr L Buée)

June 2019: Vice-President of the ‘Société des Sciences, des Arts et de l’Agriculture de Lille (SAAL)”

Research Interest: perinatal programming of metabolic disease, neuroendocrinology, Alzheimer disease, adaptation to stress.

Skype ID:  didier vieau (didiervieau@hotmail.com)

List of Publications:

Original papers

Ao 1. Vieau D, Massias JF, Girard F, Luton JP and Bertagna X. 1989. Corticotrophin like-intermediary lobe peptide as a marker of alternate proopiomelanocortin processing in ACTH producing non-pituitary tumors. Clin. Endocrinol.; 31 : 691-700.
Ao 2. Lalau JD, Vieau D, Tenenbaum F, Westeel PF, Mesmacque A, Lenne F and Quichaud J. 1990. A case of pseudo-Nelson’s syndrome : cure of ACTH hypersecretion by removal of a bronchial carcinoid tumor responsible for Cushing’s syndrome. J. Endocrinol. Invest.; 13 : 531-537.
Ao 3. de Keyzer Y, Lenne F, Massias JF, Vieau D, Luton JP, Kahn A and Bertagna X. 1990. Pituitary like proopiomelanocortin transcripts in human leydig cell tumors. J. Clin. Invest.; 86 : 871-877.
Ao 4. Massias JF, Hardouin S, Vieau D, Lenne F and Bertagna X. 1994. Phosphorylated forms of ACTH and CLIP in human tumors. Eur. J. Endocrinol.;  131 : 341-346.

Ao 5. Vieau D, Tougard C, Rosenbaum E, Lenne F and Bertagna X. 1991. The secretory granule peptide 7B2 is secreted in parallel with proopiomelanocortin and its end products by the mouse corticotrope cells At-T20. J. Neuroendocrinol.; 3 : 229-231.
Ao 6. Vieau D, Rojas-Miranda A, Verley JM, Lenne F and Bertagna X. 1991. The secretory granule peptides 7B2 and CCB are sensitive biochemicals markers of neuroendocrine bronchial tumors in man. Clin. Endocrinol.; 35 : 319-325.
Ao 7. Texier PL, de Keyzer Y, Lacave R, Vieau D, Lenne F, Rojas-Miranda A, Verley F, Luton JP, Kahn A and Bertagna X. 1991. Proopiomelanocortin gene expression in normal and tumoral human lung. J. Clin. Endocrinol. Metab.; 73 : 414-420.
Ao 8. Vieau D, Linard C, M’Bikay M, Lenne F, Chrétien M, Luton JP and Bertagna X. 1992. Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumours. Clin. Endocrinol.; 36 : 597-603.
Ao 9. Lusson J, Vieau D, Hamelin J, Day R, Chrétien M and Seidah NG. 1993. cDNA structure of the mouse and rat subtilisin/kexin-like PC5 : a candidate proprotein convertase expressed in endocrine and nonendocrine cells. Proc. Natl. Acad. Sci. USA; 90 : 6691-6695.
Ao 10. Dong W, Marcinkiewicz M, Vieau D, Chrétien M, Seidah NG and Day R. 1995. Distinct mRNA expression of the highly homologous convertases PC5 and PACE4 in the rat brain and pituitary. J. Neuroscience; 15 : 1778-1796.
Ao 11. Vieau D, Seidah NG and Day R. 1995. Characterization of prodynorphin derived products in the mouse pancreatic tumoral cell line TC3 : a unique model for the study of prodynorphin processing. Endocrinology; 136 : 1187-1196.
Ao 12. Vieau D, Seidah NG, M’Bikay M, Chrétien M and Bertagna X. 1994. Expression of the prohormone convertase PC2 correlates with the presence of CLIP in human ACTH secreting tumors. J. Clin. Endocrinol. Metab.; 75 : 1503-1506. 
Ao 13. Tostivint H, Lihrmann I, Bucharles C, Vieau D, Coulouarn Y, Fournier A, Conlon JM and Vaudry H. 1996. Occurrence of two somatostatin variants in the frog brain : characterization of the cDNAs, distribution of the mRNAs and receptor-binding affinities of the peptides. Proc. Natl. Acad. Sci. USA; 93 : 12605-12610.
Ao 14. Vieau D, Gangnon F, Jégou S, Danger JM and Vaudry H. 1998. Characterization of the cDNA encoding the prohormone convertase PC2 and localization of the mRNA in the brain of the frog Rana ridibunda. Mol. Brain. Res.; 63 : 1-13.
Ao 15. Gangnon F, Danger JM, Jégou S, Vieau D, Seidah NG and Vaudry H. 1999. Molecular cloning, characterization of the cDNA, and distribution of mRNA encoding the frog prohormone convertase PC1. J. Comp. Neurol.; 405 : 160-172.
Ao 16. Tostivint H, Vieau D, Chartrel N, Boutelet I, Galas L, Fournier A, Lihrmann I and Vaudry H. 2002. Expression and processing of the Pro2,Met13Somatostatin-14 precursor in the intermediate lobe of the frog pituitary. Endocrinology ; 143 : 3472-3481. 1er auteur ex æquo.

Ao 17. Sebaai N, Lesage J, Vieau D, Alaoui A, Dupouy JP, Deloof S. 2002. Altered control of the hypothalamo-pituitary-adrenal axis in adult male rats exposed perinatally to food deprivation and/or dehydration. Neuroendocrinology ; 76 : 243-253.
Ao 18. Gangnon F, Jegou S, Vallarino M, Vieau D and Vaudry H. 2003. Molecular characterization of the cDNA and localization of the mRNA encoding the Prohormone Convertase PC5-A in the European Green Frog. J. Comp. Neurol. ;456 : 60-72.

Ao 19. Matias I, Leonhardt M, Lesage J, De  Petrocellis L, Dupouy JP, Vieau D, Di Marzo V. 2003. Effect of maternal under-nutrition on pup body weight and hypothalamic endocannabinoid levels. Cell Mol Life Sci. ; 60 : 382-389.

Ao 20. Deloffre L, Salzet B, Vieau D, Andries JC, Salzet M. 2003. Antibacterial properties of hemerythrin of the sand worm Nereis diversicolor. Neuro Endocrinol Lett. ; 24 : 39-45.

Ao 21. Lesage J, Del-Favero F, Leonhardt M, Louvart H, Maccari S, Vieau D, Darnaudery M. 2004. Prenatal stress induces intrauterine growth restriction and programmes glucose intolerance and feeding behaviour disturbances in the aged rat. J. Endocrinol. ; 181: 291-296. 

Ao 22. Deloffre L, Sautiere PE, Huybrechts R, Hens K, Vieau D, Salzet M. 2004. Angiotensin-converting enzyme inhibition studies by natural leech inhibitors by capillary electrophoresis and competition assay. Eur. J. Biochem. ; 271: 2101-2106.

Ao 23. Sebaai N, Lesage J, Breton C, Vieau D, Deloof S. 2004. Perinatal food deprivation induces marked alterations of the hypothalamo-pituitary-adrenal axis in 8-month-old male rats both under basal conditions and after a dehydration period. Neuroendocrinology; 79 : 163-173.

Ao 24. Riviere G, Michaud A, Deloffre L, Vandenbulcke F, Levoye A, Breton C, Corvol P, Salzet M, Vieau D. 2004. Characterization of the first non-insect invertebrate functional angiotensin-converting enzyme (ACE): leech TtACE resembles the N-domain of mammalian ACE. Biochem J. ; 382 : 565-573.

Ao 25. Vergote D, Sautiere PE, Vandenbulcke F, Vieau D, Mitta G, Macagno ER, Salzet M. 2004. Up-regulation of neurohemerythrin expression in the central nervous system of the medicinal leech, Hirudo medicinalis, following septic injury. J. Biol. Chem. ; 279 : 43828-43837.

Ao 26. Levoye A, Mouillac B, Riviere G, Vieau D, Salzet M, Breton C. 2005. Cloning, expression and pharmacological characterization of a vasopressin-related receptor in an annelid, the leech Theromyzon tessulatum. J. Endocrinol. ; 184 : 277-289.

Ao 27. Laborie C, Dutriez-Casteloot I, Montel V, Dickes-Coopman A, Lesage J, Vieau D. 2005. Prenatal morphine exposure affects sympathoadrenal axis activity and serotonin metabolism in adult male rats both under basal conditions and after an ether inhalation stress. Neurosci. Lett. ; 381:211-216.

Ao 28. Rivière G, Michaud A, Breton C, VanCamp G, Laborie C, Enache M, Lesage J, Deloof S, Corvol P, Vieau D. 2005. ACE2 and ACE display tissue-specific sensitivity to programmed hypertension by maternal undernutrition in the adult rat. Hypertension ; 46: 1169-1174.
Ao 29. Molendi-Coste O,  Grumolato L, Laborie C, Lesage J, Maubert E, Ghzili H, Vaudry H, Anouar Y, Breton C, Vieau D. 2006. Maternal perinatal undernutrition alters neuronal and neuroendocrine differentiation in the rat adrenal medulla at weaning. Endocrinology ; 147 : 2050-2059.
Ao 30. Salomé N, Viltart O, Lesage J, Landgraf R, Vieau D, Laborie C. 2006. Altered hypothalamo-pituitary-adrenal and sympatho-adrenomedullary activities in rats bred for high anxiety: central and peripheral correlates. Psychoneuroendocrinology ; 31 : 724-735.
Ao 31. Vallarino M, Bruzzone F, Mathieu M, Chartrel N, Vieau D, Ciarlo M, Fournier A, Vaudry H. 2006. Ontogeny of the somatostatin variant [Pro(2), Met(13)]somatostatin-14 in the brain, pituitary, and sensory organs of the frog Rana esculenta. J. Comp. Neurol. ; 497: 717-733.
Ao 32 Brulle F, Mitta G, Cocquerelle C, Vieau D, Lemiere S, Lepretre A, Vandenbulcke F. 2006. Cloning and real-time PCR testing of 14 potential biomarkers in Eisenia fetida following cadmium exposure. Environ. Sci. Technol. 40: 2844-2850.
Ao 33. Van Waes V, Enache M, Dutriez I, Lesage J, Morley-Fletcher S, Vinner E, Lhermitte M, Vieau D, Maccari S, Darnaudery M. 2006. Hypo-response of the hypothalamic-pituitary-adrenocortical axis after an ethanol challenge in prenatally stressed adolescent male rats. Eur. J. Neurosci. 2:1193-200. 
Ao 34. Mairesse  J, Lesage J, Breton C, Bréant B, Hahn T, Darnaudéry M, Dickson S, Seckl J, Vanbesien-Mailliot C, Blondeau B, Vieau D, Maccari S, Viltart O. 2007. Maternal stress alters endocrine function of the feto-placental unit in rats. Am. J. Physiol. Endocrinol. Metab. 292 :E1526-E1533.
Ao 35. Rivière G, Michaud A, Corradi HR, Cogez V, Sturrock ED, Acharya KR, Bohin JP, Vieau D, Corvol P. 2007. Characterization of the first angiotensin-converting-like enzyme in bacteria : ancestor XcACE is already active. Gene 399: 81-90.
Ao 36. Dutriez-Casteloot, Breton C, Coupé B, Hawchar O, de Keyzer Y, Deloof S, Lesage J, Vieau D. 2008. Distribution and tissue-specific programming expression of glucocorticoid receptors and 11beta-HSDs by maternal perinatal undernutrition in the adult male rat: focus on HPA axis. Horm.Metab.Res. 40: 257-261.

Ao 37. Molendi-Coste O, Mairesse J, Aubert N, H. Ghzili H, Abbadie C, Vaudry H, Gonzalez B, Anouar Y, Vieau D, Breton C, Laborie C. 2008. Maternal perinatal undernutrition impairs chromaffin cells proliferation in the postnatal rat. Horm. Metab. Res. 40 : 386-390.
Ao 38. Grumolato L, Ghzili H, Montero-Hadjadje M, Lesage J, Galas L, Ait-Ali D, Guerineau N, Elkahloun A, Fournier A, Vieau D, Vaudry H, Anouar Y. 2008. Selenoprotein T is a PACAP- and cAMP responsive gene that localizes to the ER and regulates intracellular calcium. FASEB J. 22:1756-1768.
Ao 39. Delahaye F, Breton C, Risold PY, Enache M, Dutriez-Casteloot I, Laborie C, Lesage J, Vieau D. 2008. Maternal Perinatal Undernutrition Impedes Postnatal Leptin Surge and Affects the Development of Arcuate Nucleus POMC Neurons in Neonatal Male Rat Pups. Endocrinology 149 :470-475.

Ao 40. Coupé B, Dutriez-Casteloot I, Breton C, Lefèvre F, Mairesse J, Dickes-Coopman A, Silhol M,  Tapia-Arancibia L, Lesage J, Vieau D. 2009. Maternal undernutrition modifies brain-derived neurotrophic factor expression and cell proliferation in the hippocampus and hypothalamus of the developing male rat. J. Neuroendocrinol. 21:40-48.
Ao 41. Molendi-Coste O, Laborie C, Scarpa MC, Montel V, Vieau D, Breton C. Maternal perinatal undernutrition alters postnatal development of chromaffin cells in the male rat adrenal medulla. Neuroendocrinology 90:54-66.
Ao 42. Breton C, Risold PY, Lukaszewski MA, Enache M, Guillemot J, Rivière G, Delahaye F, Lesage J, Dutriez-Casteloot I, Laborie C, Vieau D. 2009. Maternal prenatal undernutrition alters the response of POMC neurons to energy status variation in adult male rat offspring. Am. J. Physiol. Endocrinol. Metab. 296: E462-E472.
Ao 43. Delahaye F, Lukaszewski MA, Cisse O, Dutriez-Casteloot I, Montel V, Dickes-Coopman A, Laborie C, Lesage J, Breton C, Vieau D. 2010. Maternal perinatal undernutrition programs a « brown-like » phenotype of gonadal white fat in male rat at weaning. Am J Physiol Regul Integr Comp Physiol. 299: R101-R110.

Ao 44. Mayeur S, Silhol M, Moitrot E, Barbaux S, Breton C, Gabory A, Vaiman D, Dutriez-Casteloot I, Fajardy I, Vambergue A, Tapia-Arancibia L, Bastide B, Storme L, Junien C, Vieau D, Lesage J. 2010. The placental BDNF/TRKB signaling system is modulated by fetal growth in rat and human. Placenta 31: 785-791.
Ao 45 Gallou-Kabani C., Gabory A., Tost J., Karimi M., Mayeur S., Lesage J., Boudadi E., Gross M.S., Taurelle J., Vige A., Breton C., Reusens B., Remacle C., Vieau D., Ekström T., Jais J.P., Junien C. 2010. Sex- and diet-specific dysregulation of imprinted gene expression and DNA methylation in mouse placenta under a high-fat diet. PLoS One 5: e14398.
Ao 46. Rivière G, Lienhard D, Andrieu T, Vieau D, Frey BM, Frey FJ. 2011. Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics 6:478-89.
Ao 47. Tanguy Y., Falluel-Morel A., Arthaud S., Boukhzar L., Manecka D.L., Chagraoui A., Prevost G., Elias S., Dorval-Coiffec I., Lesage J., Vieau D., Lihrmann I., Jégou B., Anouar Y. 2011. The PACAP-regulated gene selenoprotein T is highly induced in nervous, endocrine, and metabolic tissues during ontogenetic and regenerative processes. Endocrinology 152: 4322-35.
Ao 48. Laborie C., Molendi-Coste O., Breton C., Montel V., Vandenbulcke F., Grumolato L., Anouar Y., Vieau D. 2011. Maternal perinatal undernutrition has long-term consequences both on morphology, function and gene expression of the adrenal medulla in the adult male rat. J. Neuroendocrinol. 23: 711-24.
Ao 49. Guillemot J.*, Lukaszewski M.A.*, Montel V., Delahaye F., Mayeur S., Laborie C., Dickes-Coopman A., Dutriez-Casteloot I., Lesage J., Breton C., Vieau D. 2011. Influence of prenatal undernutrition of clozapine and aripiprazole in the adult male rat: relevance to a neurodevelopmental origin of schizophrenia. Eur. J. Pharmacol. 667: 402-9. (*co-premier auteur).
Ao 50.  Lukaszewski M.A., Mayeur S., Fajardy I., Delahaye F., Dutriez-Casteloot I., Montel V., Dickes-Coopman A., Laborie C., Lesage J., Vieau D., Breton C. 2011. Maternal prenatal undernutrition programs adipose tissue gene expression in adult male rat offspring under high-fat diet. Am. J. Physiol. Endocrinol. Metab. 301: E548-59.
Ao 51. Ivars J., Butruille L., Knauf C., Bouckenooghe T., Mayeur S., Vieau D., Valet P., Deruelle P., Lesage J. 2012. Maternal hypertension induces tissue-specific modulations of the apelinergic system in the fetoplacental unit in rat. Peptides 35: 136-8.
Ao 52. Gabory A., Ferry L. Fajardy I., Jouneau L., Gothié J.D., Vigé A., Fleur C., Mayeur S., Gallou-Kabani C., Gross M.S., Attig l., Vambergue A., Lesage J., Reusens B., Vieau D., Remacle C., Jais J.P., Junien C. 2012. Maternal diets trigger sex-specific divergent trajectories of gene expression and epigenetic systems in mouse placenta. PLoS One 7: e47986.
Ao 53. Mayeur S., Lancel S., Theys N., Lukaszewski M.A., Duban-Deewer S., Bastide B., Hachani J., Cecchelli R., Breton C., Gabory A., Storme L., Reusens B., Junien C., Vieau D., Lesage J. 2013. Maternal caloric restriction induces placental mitochondrial biogenesis, optimizes bioenergetic efficiency but alterates ATP production: putative involvement of mitochondria in feto-placental growth defects. Am. J. Physiol. Endocrinol. Metab. 304: E14-22.
    Ao 54. Lukaszewski M.A., Butruille L., Moitrot E., Montel V., Dickes-Coopman A., Lesage J., Laborie C., Vieau D., Breton C. 2013. The hypothalamic POMC gene expression exhibits long-term programming in prenatally undernourished male rat offspring under high-fat diet. Peptides 43: 146-54.
    Ao 55. Cisse O., Fajardy I., Dickes-Coopman A., Moitrot E., Montel V., Deloof S., Rousseaux J., Vieau D., Laborie C. 2013. Mild gestational hyperglycemia in rat induces fetal overgrowth and modulates placental growth factors and nutrient transporters expression. PLoS One 8: e64251.
Ao 56. Mayeur S., Cisse O., Gabory A., Barbaux S., Vaiman D., Vambergue A., Fajardy I., Deloof S., Junien C., Laborie C., Vieau D., Lesage J. 2013. Placental expression of the obesity-associated gene FTO is reduced by fetal growth restriction but not by macrosomia in rat and human. J. Dev. Orig. Health Dis. 4: 134-138.
Ao 57. Wattez JS, Ravallec R, Cudennec B, Knauf C, Dhulster P, Valet P, Breton C, Vieau D, Lesage J.2013. Apelin stimulates both cholecystokinin and glucagon-like peptide 1 secretions in vitro and in vivo in rodents. Peptides. Oct;48:134-6.

Ao 58. Drougard A, Duparc T, Brenachot X, Carneiro L, Gouazé A, Fournel A, Geurts L, Cadoudal T, Prats AC, Pénicaud L, Vieau D, Lesage J, Leloup C, Benani A, Cani PD, Valet P, Knauf C.2014. Hypothalamic Apelin/Reactive Oxygen Species Signaling Controls Hepatic Glucose Metabolism in the Onset of Diabetes. .Antioxid Redox Signal. 20 : 557-573.

Ao 59. Wattez JS, Delahaye F, Barella LF, Dickes-Coopman A, Montel V, Breton C, Mathias P, Foligné B, Lesage J, Vieau D. 2014. Short- and long-term effects of maternal perinatal undernutrition are lowered by cross-fostering during lactation in the male rat. J. Dev. Orig. Health Dis. Doi: 10.1017/S2040174413000548: 1-12.

Ao 60. Elmhiri G, Barella LF, Vieau D, Camous S, Mathias PC, Abdennebi-Najar L. 2014. Acute exposure to a precursor of Advanced Glycation End Products induces a dual effect on the rat pancreatic islet function. Int Journal Endocrinol 2014:378284.

Ao 61. Wattez JS, Delmont A, Bouvet M, Beseme O, Goers S, Delahaye F, Laborie C, Lesage J, Foligné B, Breton C, Metges C, Vieau D, Pinet . 2015. Maternal perinatal undernutrition modifies lactose and serotransferrin in milk: relevance to the programming of metabolic diseases? Am J Physiol Endocrinol Metab, 308 : E393-E401. Dernier auteur ex aequo.

Ao 62. Malta A, de Moura EG, Ribeiro TA, Tófolo LP, Abdennebi-Najar L, Vieau D, Barella LF, de Freitas Mathias PC, Lisboa PC, de Oliveira JC. 2016. Protein-energy malnutrition at mid-adulthood does not imprint long-term metabolic consequences in male rats. Eur J Nutr. 55(4):1423-33.

Ao 63. Mayeur S, Wattez JS, Lukaszewski MA, Lecoutre S, Butruille L, Drougard A, Eberlé D, Bastide B, Laborie C, Storme L, Knauf C, Vieau D, Breton C, Lesage J. 2016. Apelin Controls Fetal and Neonatal Glucose Homeostasis and Is Altered by Maternal Undernutrition. Diabetes. 65(3):554-60.

Ao 64. Lecoutre S, Deracinois B, Laborie C, Eberlé D, Guinez C, Panchenko PE, Lesage J, Vieau D, Junien C, Gabory A, Breton C. 2016. Depot- and sex-specific effects of maternal obesity in offspring's adipose tissue. J Endocrinol 230 : 39-53.

Ao 65. Lecoutre S, Marousez L, Drougard A, Knauf C, Guinez C, Eberlé D, Laborie C, Vieau D, Lesage J, Breton C. 2017. Maternal undernutrition programs the apelinergic system of adipose tissue in adult male rat offspring. J Dev Orig Health Dis. Feb;8(1):3-7.

Ao 66. Marciniak E, Leboucher A, Caron E, Ahmed T, Tailleux A, Dumont J, Issad T, Gerhardt E, Pagesy E, Vileno M, Bournonville C, Hamdane M, Bantubungi K, Lancel S, Demeyer D, Eddarkaoui S, Vallez E, Vieau D, Humez S, Faivre E, Grenier-Boley B, Outeiro TF, Staels B, Amouyel P, Balschun D, Buee L, Blum D. 2017. Tau deletion promotes brain insulin resistance. J Exp Med.214 (8): 2257-2269.
Ao 67. Lecoutre S, Oger F, Butruille L, Marousez L, Dickes-Coopman A, Pourpe C, Laborie C, Eberlé D, Guinez C, Lesage J, Vieau D, Junien C, Gabory A, Eeckhoute J, Breton C. 2017. Maternal obesity affects leptin gene expression in rat male offspring via epigenetic modifications in a depot-specific manner. Molecular Metab.6 (8): 922-930.
Ao 68. Lecoutre S, Pourpe C, Butruille L, Marousez L, Laborie C, Guinez C, Lesage J, Vieau D, Eeckhoute J, Gabory A, Oger F, Eberle D, Breton C. 2018. Reduced PPARgamma 2 expression in adipose tissue of male rat offspring from obese dams is associated with epigenetic modifications. Faseb J. Jan 2. pii: fj.201700997R. doi: 10.1096/fj.201700997R.
Ao 69. Cissé O, Fajardy I, Delahaye F, Dickes A, Montel V, Moitrot E, Breton C, Vieau D, Laborie C. 2018. Effect of diet in females (F1) from prenatally undernourished mothers on metabolism and liver function in the F2 progeny is sex-specific. Eur J Nutr. doi: 10.1007/s00394-018-1794-y.

Ao 70. Leboucher A, Ahmed T, Caron E, Tailleux A, Raison S, Joly-Amado A, Marciniak E, Carvalho K, Hamdane M, Bantubungi K, Lancel S, Eddarkaoui S, Caillierez R, Vallez E, Staels B, Vieau D, Balschun D, Buee L, Blum D. 2019. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model. Neurobiol Dis. 125:14-22.

Reviews and chapters of books

R1. Vieau D, Gicquel C et Proeschel MF. 1991. La proopiomélanocortine et ses fragments : applications à l’investigation clinique. Médecine Sciences; 7: 918-926.
R2. Day R, Vieau D and Seidah NG. 1994. Approaches in the study of the posttranslational processing of opioid peptide precursors : focus on prodynorphin. Regul. Peptides; 54 : 77-78.
R3. Raffin-Sanson ML, Vieau D, de Keyzer Y et Bertagna X. 1995. Hormones corticolipotropes et endorphines. Encyclopédie Médico-chirurgicale.
R 4. de Keyzer Y, Vieau D, Picon A and Bertagna X. 1996. Molecular aspects of the ectopic ACTH syndrome. Endocrine-Related Cancer; 3 : 99-112.
R5. Tostivint H, Lihrmann I, Bucharles C, Vieau D, Coulouarn Y, Fournier A, Conlon JM, Vaudry H, Dournaud P, Gardette R, Viollet C et Epelbaum J. 1996. Un deuxième gène codant pour la somatostatine est exprimé dans le cerveau. Médecine Sciences; 12 : 1131-1133.
R6. Chartrel N, Braun B, Collin F, Pierreuse B, Coulouarn Y, Tostivint H, Jeandel L, Trabucchi M, Vieau D, Lihrmann I, Tonon MC, Anouar Y, Conlon JM et Vaudry H. 1998. Stratégie d’identification de nouveaux neuropeptides. CR. Soc. Biol.; 192 : 619-638.
R7. Tostivint H, Lihrmann I, Bucharles C, Vieau D, Coulouarn Y, Boutelet I, Fournier A, Conlon JM, Vaudry H. 1998. A second somatostatin gene is expressed in the brain of the frog Rana ridibunda . Trends in Comparative Endocrinology and Neurobiology. Annals of the New York Academy of sciences 839: 496-497.

R8. Salzet M, Vieau D and Stefano G. 1999. Serpins : a survival strategy in immunity. Immunol. Today ; 20 : 541-544. Ce journal est devenu Trends in Immunology.
R9. Salzet M, Vieau D and Day R. 2000. Crosstalk between nervous and immune systems through the animal kingdom : focus on opioids. Trends in Neuroscience; 23 : 550-555.
R10. Tasiemski A, Lefebvre C, Vieau D and Salzet M. 2000. Immune response stimulation pathway : implications of opioid peptides. Crit. Trends in Immunol.; 2 : 209-216.
R11. Salzet M, Deloffre L, Breton C, Vieau D and Schoofs L. 2001. The angiotensin system elements in invertebrates. Brain Res. Rev. ; 36 : 35-45.
R12. Gangnon F, Danger JM, Jégou S, Vieau D, Vaudry H. 2002. Characterization of the three prohormone-convertases potentially involved in the processing of neuropeptide precursors in the european green frog. Proceedings of the 21st Conference of European Comparative Endocrinologists : 507-512.
R13. Gangnon F, Vieau D, Jégou S and Vaudry H. 2003. Cloning of the cDNA and comparative distribution of frog PC1 and PC2, the major proteolytic enzymes involved in the processing of neuropeptides. Recent Progress in Comparative Endocrinology and Neurobiology.
R14. Chartrel N, Braun B, Desrues L, Yon L, Vieau D, Kodjo M, Cellier E, Kikuyama S, Delarue C, Tonon MC and Vaudry H. 2003. Identification of novel neuropeptides from the amphibian brain. Recent Progress in Comparative Endocrinology and Neurobiology.
R15. Salzet M., Vieau, D., Breton, C. 2004. Cell signalling in prokaryotes and lower metazoa. (Ed. Fairweather I), Kluwer Publisher. Evidence for an annelid neuroendocrine system (Chapter 9).
R16. Lesage J, Sebaai N, Léonhardt M, Dutriez-Casteloot I, Breton C, Deloof S, Vieau D. 2006. Maternal undernutrition and HPA axis in the offspring. Stress ; 9 : 183-198.
R17. Vieau D, Sebaai N, Léonhardt M, Dutriez-Casteloot I, Molendi-Coste O, Laborie C, Breton C, Deloof S, Lesage J. 2007. HPA axis programming by maternal undernutrition in the male rat offspring. Psychoneuroendocrinology 32 (supl 1): S16-S20.
R18. Vieau D, Mayeur S, Lukaszewski MA, Delahaye F, Dutriez-Casteloot I, Laborie C, Deloof, S, Lesage J, Breton C. 2009. Perinatal undernutrition and brain derived nerve factor. The International Handbook of behavior, diet and nutrition.
R19. Vieau D. 2009. La dénutrition maternelle programme les systèmes neuroendocriniens impliqués dans la réponse au stress chez le rat mâle adulte : rôle dans la genèse du syndrome métabolique ? Médecine et nutrition 45 (1) : 1-6.
R20. Vieau D. 2009. Maternal undernutrition programs hypothalamo-pituitary-adrenal (HPA) axis activity. Endocrinologia & Diabetes Clinica e experimental 9 (4): 1068-1070.
R21. Mayeur S., Lukaszewski M.A., Breton C., Storme L., Vieau D., Lesage J. 2011. Do neurotrophins regulate the feto-placental development? Med. Hypotheses 76: 726-8.
R22. Vieau D. 2011. Perinatal nutritional programming of health and metabolic adult disease. World J Diabetes 2: 133-6.
R23. Mayeur S., Lukaszewski M.A., Breton C., Storme L., Junien C., Vieau D., Lesage J.  2011. BDNF in feto-placental development. Med. Sci. (Paris) 27: 251-2.
R 24. Guillemot J., Laborie C., Dutriez-Casteloot I., Maron M., Deloof S., Lesage J., Breton C., Vieau  D. 2011. Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring? Eur. J. Pharmacol. 667: 13-6.
R25. Lukaszewski M.A., Delahaye F., Vieau D., Breton C. 2012. Is the adipose tissue a key target of developmental programming of adult adiposity by maternal undernutrition? Adipocyte 1:64-7.
R26. Wattez J.S., Delahaye F., Lukaszewski M.A., Eberlé D., Vieau D., Breton C. 2013. Maternal nutrition programs hypothalamic POMC neurons in the offspring. Horm. Metab. Res. 45: 980-990.
    R27. Vieau D., Breton C., Dutriez-Casteloot I., Montel V., Dickes-Coopman A., Deloof S., Lesage J., Laborie C. 2011. Maternal perinatal undernutrition programs stress neuroendocrine systems in the male rat. Lee JE. Undernutrition: Effects, Causes and Management. Hauppage, New York: Nova Science Publishers, 1-23.
    R28. Vieau D., Mayeur S., Dutriez-Casteloot I., Lukaszewski M.A., Delahaye F.,  Laborie C., Deloof S., Lesage J., Breton C. 2013. Perinatal undernutrition and brain derived factor. International Handbook of Behavior, Diet and Nutrition (Preedy V.R., eds.), Springer.
R29. Lukaszewski MA, Eberlé D, Vieau D, Breton C. 2013. Nutritional manipulations in the perinatal period program adipose tissue in offspring. Am J Physiol Endocrinol Metab. 305 : E1195-E1207.

R30. Vieau D, Laborie C, Eberlé D, Lesage J, Breton C. 2016. Nutrition périnatale et programmation : le tissu adipeux est en dans le collimateur. Médecine Sciences 32 : 81-84.

R31. Vercruysse P, Vieau D, Blum D, Petersen A, Dupuis L. 2018. Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front. Mol. Neurosci. 11:2. doi: 10.3389/fnmol.2018.00002.

R32. Gratuze M, Joly-Amado A, Vieau D, Buée L, Blum D. 2018. Mutual relationship between Tau and central insulin signalling: consequences for Alzheimer disease and Tauopathies. Neuroendocrinology 107(2):181-195.

R33. Cellai L, Carvalho K, Faivre E, Deleau A, Vieau D, Buée L, Blum D, Mériaux C, Gomez Murcia V. 2018. The adenosinergic signaling : a complex but promising therapeutic target for Alzheimer’s disease. Front. Neurosci. 12:520.

R34. Joly-Amado A, Gratuze M, Benderradji H, Vieau D, Buée L, Blum D. 2018. Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies. Med Sci (Paris). 2018 Nov;34(11):929-935.

Research Interest: Clinical Cardiology; Clinical Pharmacology; Cardiovascular Physiology; Arterial Hypertension; Blood Pressure Monitoring; Telemedicine.

2 Parati G, Ravogli A, Bragato R, OMBONI S, Mutti E, Mancia G. Clinical and hemodynamic effects of celiprolol in essential hypertension. J Cardiovasc Pharmacol 1989;7:S14-21.
3 Mancia G, Groppelli A, Casadei R, OMBONI S, Mutti E, Parati G. Cardiovascular effects of smoking. Clin Exp Hypertens A 1990;5:917-29.
4 Parati G, Castiglioni P, Di Rienzo M, OMBONI S, Pedotti A, Mancia G. Sequential spectral analysis of 24-hour blood pressure and pulse interval in humans. Hypertension 1990;4:414-21.
5 Groppelli A, OMBONI S, Parati G, Mancia G. Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition. J Hypertens Suppl 1990;5:S35-40.
6 Mutti E, Trazzi S, OMBONI S, Parati G, Mancia G. Effect of placebo on 24-h non-invasive ambulatory blood pressure. J Hypertens 1991;4:361-4.
7 Parati G, Trazzi S, Ravogli A, Casadei R, OMBONI S, Mancia G. Methodological problems in evaluation of cardiovascular effects of stress in humans. Hypertension 1991;4 Suppl:III50-5.
8 Groppelli A, OMBONI S, Ravogli A, Villani A, Parati G, Mancia G. Validation of the SpaceLabs 90202 and 90207 devices for ambulatory blood pressure monitoring by comparison with intra-arterial resting and ambulatory measurements. J Hypertens Suppl 1991;6:S334-5.
9 Trazzi S, OMBONI S, Mutti E, Parati G, Zanchetti A, Mancia G. Acute modulation of arterial compliance in mild essential hypertension. J Hypertens Suppl 1991;6:S110-1.
10 Zito M, Parati G, OMBONI S, Cervone C, Ulian L, D'Aviero M, Abate G, Mancia G. Effect of ageing on blood pressure variability. J Hypertens Suppl 1991;6:S328-9.
11 OMBONI S, Ravogli A, Parati G, Zanchetti A, Mancia G. Prognostic value of ambulatory blood pressure monitoring. J Hypertens Suppl 1991;3:S25-8.
12 Parati G, Groppelli A, OMBONI S, Trazzi S, Frattola A, Mancia G. Testing the accuracy of blood pressure monitoring devices in ambulatory conditions. J Hypertens Suppl 1991;8:S7-9.
13 Di Rienzo M, Parati G, Castiglioni P, OMBONI S, Ferrari AU, Ramirez AJ, Pedotti A, Mancia G. Role of sinoaortic afferents in modulating BP and pulse-interval spectral characteristics in unanesthetized cats. Am J Physiol 1991;6 Pt 2:H1811-8.
14 Groppelli A, Giorgi DM, OMBONI S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992;5:495-9.
15 Giannattasio C, Cattaneo BM, OMBONI S, Seravalle G, Bolla G, Turolo L, Morganti A, Grassi G, Zanchetti A, Mancia G. Sympathomoderating influence of benazepril in essential hypertension. J Hypertens 1992;4:373-8.
16 Mancia G, OMBONI S, Parati G, Trazzi S. Twenty-four hour blood pressure monitoring and end-organ damage. Blood Press Suppl 1992;1:38-41.
17 Mancia G, Frattola A, OMBONI S, Parati G, Rarogli A. Twenty-four-hour blood pressure and antihypertensive treatment. Blood Press Suppl 1992;1:44-5.
18 Parati G, OMBONI S, Di Rienzo M, Frattola A, Albini F, Mancia G. Twenty-four hour blood pressure variability:clinical implications. Kidney Int Suppl 1992;37:S24-8.
19 Groppelli A, OMBONI S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension 1992;2:227-32.
20 Trazzi S, OMBONI S, Santucciu C, Parati G, Mancia G. Variability in arterial diameter and compliance:compliance modulation reserve. J Hypertens Suppl 1992;6:S41-3.
21 Villani A, Parati G, Groppelli A, OMBONI S, Di Rienzo M, Mancia G. Noninvasive automatic blood pressure monitoring does not attenuate nighttime hypotension. Evidence from 24 h intraarterial blood pressure monitoring. Am J Hypertens 1992;10:744-7.
22 Mancia G, OMBONI S, Ravogli A, Frattola A, Villani A. Ambulatory blood pressure monitoring. Drugs 1992;1:17-22.
23 OMBONI S, Frattola A, Parati G, Ravogli A, Mancia G. Clinical value of blood pressure measurements:focus on ambulatory blood pressures. Am J Cardiol. 1992;12:4D-8D.
24 Mancia G, OMBONI S, Parati G, Trazzi S, Mutti E. Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring:implications for studies on antihypertensive drugs. J Hypertens 1992;12:1531-5.
25 OMBONI S, Ravogli A, Mancia G. Ambulatory blood pressure monitoring and antihypertensive treatment. J Hum Hypertens 1992;2:S9-13.
26 Mancia G, Giannattasio C, OMBONI S. Ambulatory blood pressure monitoring and antihypertensive treatment. Eur Heart J 1992;G:43-7.
27 Mancia G, De Cesaris R, Fogari R, Lattuada S, Montemurro G, Palombo C, Porcellati C, Ranieri G, Tettamanti F, Verdecchia P, Marelli C, OMBONI S, Ravogli A, Zanchetti A, for the Italian Trandolapril Study Group. Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study Group. Am J Cardiol 1992;70:60D-66D.
28 Laurent S, Hayoz D, Trazzi S, Boutouyrie P, Waeber B, OMBONI S, Brunner HR, Mancia G, Safar M. Isobaric compliance of the radial artery is increased in patients with essential hypertension. J Hypertens 1993;1:89-98.
29 Mancia G, OMBONI S, Parati G, Santucciu C, Trazzi S, Ulian L. Clinical value of ambulatory blood pressure monitoring. Am J Hypertens 1993;3 Pt 2:9S-13S.
30 Parati G, di Rienzo M, OMBONI S, Castiglioni P, Frattola A, Mancia G. Spectral analysis of 24 h blood pressure recordings. Am J Hypertens 1993;6 Pt 2:188S-193S.
31 Mancia G, OMBONI S, Parati G, Sega R, Trazzi S. Ambulatory blood pressure monitoring in the design of studies on antihypertensive drug efficacy. Am J Hypertens 1993;6 Pt 2:233S-235S.
32 OMBONI S, Parati G, Frattola A, Mutti E, Di Rienzo M, Castiglioni P, Mancia G. Spectral and sequence analysis of finger blood pressure variability. Comparison with analysis of intra-arterial recordings. Hypertension. 1993;1:26-33.

Zanchetti A, Bianchi L, Amigoni S, OMBONI S, Villani A, Ravogli A. Antihypertensive effects of nifedipine gastrointestinal therapeutic system on clinic and ambulatory blood pressure in essential hypertensives. Italian GITS Study Group. J Hypertens Suppl 1993;5:S334-5.
34 Pomidossi G, Saino A, Perondi R, Gregorini L, Alessio P, Rimini A, OMBONI S, Zanchetti A, Mancia G. Impairment of the arterial baroreflex during symptomatic and silent myocardial ischemia in humans. J Am Coll Cardiol 1993;7:1866-72.
35 Ravogli A, OMBONI S, De Cesaris R, Fogari R, Lattuada S, Montemurro G, Palombo C, Porcellati C, Ranieri G, Tettamanti C. Twenty-four-hour ambulatory blood pressure monitoring and antihypertensive treatment:focus on ACE inhibitors. J Cardiovasc Pharmacol 1994;1:S15-9.
36 Mancia G, OMBONI S, Parati G, Ravogli A, Sega R, Ulian L. Ambulatory blood pressure monitoring in the diagnosis of hypertension and evaluation of antihypertensive drug efficacy. Blood Press Suppl 1994;2:20-2.
37 Mancia G, Frattola A, Groppelli A, OMBONI S, Parati G, Ulian L, Villani A. Blood pressure reduction and end-organ damage in hypertension. J Hypertens Suppl 1994;8:S35-41.
38 Parati G, Ravogli A, Mutti E, Santucciu C, OMBONI S, Mancia G. Ambulatory blood pressure monitoring in the evaluation of antihypertensive drugs. J Hypertens Suppl 1994;8:S9-15.
39 OMBONI S, Smit AA, Wieling W. Twenty four hour continuous non-invasive finger blood pressure monitoring:a novel approach to the evaluation of treatment in patients with autonomic failure. Br Heart J 1995;3:290-2.
40 Mancia G, OMBONI S, Parati G, Ravogli A, Villani A, Zanchetti A. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995;3:311-5.
41 Mancia G, OMBONI S, Ravogli A, Parati G, Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment:additional information from a large data base. Blood Press 1995;3:148-56.
42 Parati G, Di Rienzo M, OMBONI S, Ulian L, Mancia G. Blood pressure variability over 24 hours:its different components and its relationship to the arterial baroreflex. J Sleep Res 1995;S1:21-29.
43 Mancia G, Giannattasio C, Turrini D, Grassi G, OMBONI S. Structural cardiovascular alterations and blood pressure variability in human hypertension. J Hypertens Suppl 1995;2:S7-14.
44 OMBONI S, Parati G, Zanchetti A, Mancia G. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure:methodological aspects. J Hypertens 1995;10:1105-12.
45 OMBONI S, Ravogli A, Villani A, Mancia G. Permanent blood pressure control over the 24 h by trandolapril. Am J Hypertens 1995;10 Pt 2:71S-74S.
46 Thijs L, Dabrowska E, Clement D, Fagard R, Laks T, Mancia G, O'Brien E, OMBONI S, Parati G, Staessen J, et al. Diurnal blood pressure profile in older patients with isolated systolic hypertension. The SYST-EUR Investigators. J Hum Hypertens 1995;11:917-24.
47 Parati G, Ulian L, Santucciu C, OMBONI S, Mancia G. Blood pressure variability, cardiovascular risk and antihypertensive treatment. J Hypertens Suppl 1995;4:S27-34.
48 Ravogli A, Arzilli F, OMBONI S, Giovannetti R, Mutti E, Salvetti A, Mancia G. Lack of effect of percutaneous transluminal renal angioplasty on nocturnal hypotension in renovascular hypertensive patients. J Hypertens 1996;1:53-6.
49 Parati G, Frattola A, OMBONI S, Mancia G, Di Rienzo M. Analysis of heart rate and blood pressure variability in the assessment of autonomic regulation in arterial hypertension. Clin Sci (Lond) 1996;91 Suppl:129-32.
50 Mancia G, Parati G, OMBONI S, Ravogli A, Villani A, Santucciu C, Ulian L. Ambulatory blood pressure monitoring in the ELSA study. European Lacidipine Study on Atherosclerosis. Blood Press Suppl 1996;4:36-8.
51 Mancia G, OMBONI S. Ambulatory blood pressure, blood pressure variability and antihypertensive treatment. Clin Exp Hypertens. 1996;3-4:449-62.
52 Mancia G, OMBONI S, Parati G. Lessons to be learned from 24-hour ambulatory blood pressure monitoring. Kidney Int Suppl 1996;55:S63-8.
53 Parati G, OMBONI S, Mancia G. Difference between office and ambulatory blood pressure and response to antihypertensive treatment. J Hypertens. 1996;6:791-7.
54 OMBONI S, Parati G, Di Rienzo M, Wieling W, Mancia G. Blood pressure and heart rate variability in autonomic disorders:a critical review. Clin Auton Res 1996;3:171-82.
55 Mancia G, Gamba PL, OMBONI S, Paleari F, Parati G, Sega R, Zanchetti A. Ambulatory blood pressure monitoring. J Hypertens Suppl 1996;2:S61-6;discussion S66-8.
56 OMBONI S, Parati G, Groppelli A, Ulian L, Mancia G. Performance of the AM-5600 blood pressure monitor:comparison with ambulatory intra-arterial pressure. J Appl Physiol 1997;2:698-703.
57 Mancia G, OMBONI S, Parati G. Assessment of antihypertensive treatment by ambulatory blood pressure. J Hypertens Suppl 1997;2:S43-50.
58 Mancia G, OMBONI S, Grassi G. Combination treatment in hypertension:the VeraTran Study. Am J Hypertens 1997;7 Pt 2:153S-158S.
59 Zanchetti A, OMBONI S, Di Biagio C. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension. J Hum Hypertens 1997;2:S57-9.
60 Baccelli G, Reggiani P, Mattioli A, Corbellini E, Garducci S, Catalano M, OMBONI S. Hemodynamic changes in the lower limbs during treadmill walking in normal subjects and in patients with arteriosclerosis obliterans. Angiology 1997;9:795-803.
61 Santucciu C, Parati G, Ulian L, OMBONI S, Mancia G. [The difference between clinical ambulatory measured blood pressure and daily monitored pressure does not reflect the "white coat effect"]. Cardiologia 1997;10:1067-9.
62 Parati G, OMBONI S, Staessen J, Thijs L, Fagard R, Ulian L, Mancia G. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators. J Hypertens 1998;1:23-9.
63 Mancia G, OMBONI S, Zanchetti A. Clinical advantages of lipophilic dihydropyridines. Blood Press Suppl. 1998;2:23-6.
64 Parati G, Ulian L, Santucciu C, OMBONI S, Mancia G. Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 1998;5:1185-9.
65 OMBONI S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, Mancia G. Reproducibility and clinical value of nocturnal hypotension:prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens 1998;6:733-8.

OMBONI S, Parati G, Mancia G. The trough:peak ratio and the smoothness index in the evaluation of control of 24 h blood pressure by treatment in hypertension. Blood Press Monit 1998;3:201-204.
67 OMBONI S, Parati G, Castiglioni P, Di Rienzo M, Imholz BP, Langewouters GJ, Wesseling KH, Mancia G. Estimation of blood pressure variability from 24-hour ambulatory finger blood pressure. Hypertension 1998;1:52-8.
68 OMBONI S, Fogari R, Palatini P, Rappelli A, Mancia G. Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect:evidence from the sample study. Hypertension 1998;3:424-9.
69 Mancia G, Cattaneo BM, OMBONI S, Grassi G. Clinical benefits of a consistent reduction in blood pressure. J Hypertens Suppl 1998;6:S35-9.
70 Parati G, OMBONI S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index:a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998;11:1685-91.
71 OMBONI S, Zanchetti A. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators. J Hypertens 1998;12 Pt 1:1831-8.
72 Mancia G, Parati G, OMBONI S, Ulian L, Zanchetti A. Ambulatory blood pressure monitoring. Clin Exp Hypertens 1999;5-6:703-15.
73 Castiglioni P, Parati G, OMBONI S, Mancia G, Imholz BP, Wesseling KH, Di Rienzo M. Broad-band spectral analysis of 24 h continuous finger blood pressure:comparison with intra-arterial recordings. Clin Sci (Lond) 1999;2:129-39.
74 OMBONI S, Parati G, Mancia G. [Monitoring of blood pressure for 24 hours:historical, technical, and methodological features]. Cardiologia 1999;1(Pt 2):997-1000.
75 Parati G, OMBONI S, Mancia G. [Trough-peak ratio and the smoothness index in the assessment of duration and homogeneity of 24-hour antihypertensive effect]. Cardiologia 1999;1(Pt 1):345-8.
76 Mancia G, OMBONI S, Parati G. The importance of blood pressure variability in hypertension. Blood Press Monit 2000;1:S9-S15.
77 Mancia G, OMBONI S, Agabiti-Rosei E, Casati R, Fogari R, Leonetti G, Montemurro G, Nami R, Pessina AC, Pirrelli A, Zanchetti A. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients. J Cardiovasc Pharmacol 2000;6:926-31.
78 OMBONI S, Fogari R, Mancia G. A smooth blood pressure control is obtained over 24 h by delapril in mild to moderate essential hypertensives. Blood Press 2001;3:170-5.
79 Zanchetti A, OMBONI S. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group. Am J Hypertens 2001;2:129-34.
80 Parati G, OMBONI S, Villani A, Glavina F, Castiglioni P, Di Rienzo M, Mancia G. Reproducibility of beat-by-beat blood pressure and heart rate variability. Blood Press Monit 2001;4:217-20.
81 Mancia G, OMBONI S, Parati G, Clement DL, Haley WE, Rahman SN, Hoogma RP. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens 2001;10:1755-63.
82 Zanchetti A, OMBONI S, La Commare P, De Cesaris R, Palatini P. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J Cardiovasc Pharmacol 2001;4:642-50.
83 Mancia G, Parati G, Hennig M, Flatau B, OMBONI S, Glavina F, Costa B, Scherz R, Bond G, Zanchetti A;ELSA Investigators. Relation between blood pressure variability and carotid artery damage in hypertension:baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001;11:1981-9.
84 OMBONI S, Smit AA, van Lieshout JJ, Settels JJ, Langewouters GJ, Wieling W. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure. Clin Sci (Lond) 2001;6:609-18.
85 Antonicelli R, OMBONI S, Giovanni DC, Ansuini R, Mori A, Gesuita R, Parati G, Paciaroni E. Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring. Drugs Aging 2002;7:541-51.
86 Porcellati C, OMBONI S. Switching from ACE inhibitors, beta-blockers, calcium antagonists or diuretics to candesartan improves efficacy and tolerability. Blood Press 2002;5:310-9.
87 Mancia G, OMBONI S, Parati G;Investigators of the INSIGHT ABPM substudy. Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). J Hypertens 2002;3:545-53.
88 Taddei S, OMBONI S, Ghiadoni L, Caiazza A, Fogari R, Innocenti P, Porcellati C, Giovannetti R, Corradi L, Mancia G, Salvetti A. Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients. J Cardiovasc Pharmacol 2003;4:579-85.
89 Mancia G, OMBONI S;CARDIO (CAndesaRtan combined with DIuretic in hypertensiOn) Study Group. Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients. Blood Press Suppl 2004;2:11-7.
90 Malacco E, Piazza S, OMBONI S;on behalf of the Zofenopril Study Group. Zofenopril versus Lisinopril in the Treatment of Essential Hypertension in Elderly Patients: A Randomised, Double-Blind, Multicentre Study. Clin Drug Investig 2005;3:175-182.
91 Mancia G, Parati G, Bilo G, Maronati A, OMBONI S, Baurecht H, Hennig M, Zanchetti A. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure:data from the European Lacidipine Study on Atherosclerosis. J Hypertens 2007;5:1087-94.
92 Orzalesi N, Rossetti L, OMBONI S;OPTIME Study Group (Osservatorio sulla Patologia glaucomatosa, Indagine Medico Epidemiologica);CONPROSO (Collegio Nazionale dei Professori Ordinari di Scienze Oftalmologiche). Vascular risk factors in glaucoma:the results of a national survey. Graefes Arch Clin Exp Ophthalmol 2007;6:795-802.
93 Pini C, Pastori M, Baccheschi J, OMBONI S, Parati G;European Society of Hypertension. Validation of the Artsana CSI 610 automated blood pressure monitor in adults according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007;3:179-84.
94 Bussone G, Tullo V, d'Onofrio F, Petretta V, Curone M, Frediani F, Tonini C, OMBONI S. Frovatriptan for the prevention of postdural puncture headache. Cephalalgia 2007;7:809-13.
95 OMBONI S, Riva I, Giglio A, Caldara G, Groppelli A, Parati G. Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007;4:233-42.

96. Malacco E, OMBONI S. Antihypertensive efficacy of zofenopril plus hydrochlorothiazide fixed combination for treatment in metabolic syndrome. Adv Ther 2007;5:1006-15.
97 Pecori Giraldi F, Toja PM, De Martin M, Maronati A, Scacchi M, OMBONI S,Cavagnini F, Parati G. Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure. Horm Metab Res 2007;12:908-14.
98 Pini C, Natalizi A, Gerosa PF, Frigerio M, OMBONI S, Parati G. Validation of the Artsana CS 410 automated blood pressure monitor in adults according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2008;13:177-182.
99 OMBONI S, Costantini C, Pini C, Bulegato R, Manfellotto D, Rizzoni D, Palatini P, O'brien E, Parati G. PA.NET International Quality Certification Protocol for blood pressure monitors. Blood Press Monit 2008;13:285-289.
100 Parati G, OMBONI S, Palatini P, Rizzoni D, Bilo G, Valentini M, Agabiti-Rosei E, Mancia G. Italian Society of Hypertension Guidelines for Conventional and Automated Blood Pressure Measurement in the Office, at Home and Over 24 Hours. High Blood Pressure & Cardiovascular Prevention 2008;15:283-310.

More....

Research Interest: Metabolomics Studies, Particularly on the Fetal-Neonatal Nutrition and Prevention of Chronic Diseases in Adults such as Obesity, Diabetes and Metabolic Syndrome.

Research Interest: Cardiovascular diseases, Endothelial function, Hypertension, Diabetes, Renin-angiotensin-system

Research Interest: A Biomedical Researcher with a Focus on Neurobehavioral, Metabolic and Endocrine Disorders.

Research Interest: Rehabilitation, Working with Older People, Diabetes, Stroke Care, Research 

Research Interest: Blood Brain Barrier; Neurovascular Pharmacokinetics; Stroke; Ischemia; Neurodegneration; Neuroprotection; Neuropharmacology; Nutrient and Ion Transporters; Diabetes

Research Interest: Has Experience in Physical Therapy, with an Emphasis on Cardiopulmonary Physical Therapy, Acting on the Following Topics: Health Promotion, Cardiac Rehabilitation, Exercise Prescription for People with Special Needs, Assessment of Autonomic Function, Analysis of Biological Signals, Cardiorespiratory Physiotherapy in Morbid Obesity and Physical Therapy in Intensive Care. 

Research Interest: Medicinal Herbs, Behavioral Pharmacology, Neurodegeneration, Neurotransmitters, Neuroscience, Diabetes, Inflammation

Research Interest: My Research Interests Span Many Areas Including Bioinformatics and Metabolomics. As a Phd Student at Center of Magnetic Resonance of University of Florence (Italy), My Research Focused on the Metabolomic Analysis of Biofluid (E.G., Urine, Serum, Saliva) and Tissue (E.G., Intact Human Liver) Samples. I Used Nuclear Magnetic Resonance (NMR) Spectroscopy and Advanced Statistical Analysis Techniques to Identify and Predict Metabolomic Fingerprints. In Particular, I Used NMR-Based Metabolomic Analysis to Identify a Fingerprint of Poor-Survival in the Serum of Patient with Metastatic Colorectal Cancer.
Now as Postdoc at Dana-Farber Cancer Institute, My Current Research Focuses on Identifying Metabolic Fingerprint Predictors of Prostate Cancer Development and Progression to Improve our Understanding of The Mechanisms Linking Metabolism with the Biology of Prostate Cancer. Moreover, I Will Contribute on Developing of New Standard Operation Procedures for Metabolomic Analysis in Formalin Fixed Paraffin Embedded Tissues. 

Research Interest: Metabolic and Bariatric Surgery, Gastrointestinal Surgery, Thyroid Surgery, Hepatobiliary Surgery, Hernia Surgery, Anorectal Surgery, General Surgery.